Olink

Olink®
Part of Thermo Fisher Scientific

Olink Frontiers

  • October 8, 2026
  • Multiple locations
About event
Your research evolves. Your proteomics platform should too.

Join our roadshow to discover how Olink proteomics supports the journey from broad discovery through focused validation and translation, all built on the same proven Proximity Extension Assay (PEA™) technology.

Event locations

Connect with fellow researchers and Olink specialists over refreshments at a local event

Texas Medical Center

Thursday, October 29, 2026
9:00 AM – 2:00 PM

Meet with your fellow researchers and Olink specialist over refreshments as we learn how Olink proteomics supports the journey from broad discovery through focused validation and translation, all built on the same proven Proximity Extension Assay (PEA™) technology.

Register to attend by filling out the form below.

TimeDescription

9:00 - 10:00

Coffee and networking

10:00 - 10:30

Proximity Extension Assay (PEA): Providing Disease Insights from Discovery to Disease Translation

Jess Golubski, MSc, Sr. Field Application Scientist, Olink, part of Thermo Fisher Scientific

10:30 - 11:00

Pediatric proteomic signatures of cardiometabolic disease-associated traits predict adult disease outcomes

Kari North, PhD, MA, FAHA, Professor of Epidemiology, Professor of Internal Medicine Director of the Border Health Center, UTHealth Houston School of Public Health

11:00 - 11:30

Population-level multi-omics for target discovery

Ryan Dhindsa, Assistant Professor, Department of Pathology & Immunology, Baylor College of Medicine

11:30 - 12:00

Reading Cancer Beyond DNA: The Power of Circulating Proteins

Andrea Ballagi, MD, PhD, MBA, Oncology Market Development, Olink, part of Thermo Fisher Scientific

12:00 - 1:00

Lunch

1:00 - 2:00

Networking

Register for the event

Please select the local seminar you'd like to attend.

PEA technology
Change the question. Not the technology.

The Proximity Extension Assay is a dual-recognition immunoassay that converts target recognition events into measurable qPCR or NGS signals. This technology is powering some of the world’s largest proteomics initiatives, producing large-scale proteomics data to help researchers uncover new biological connections, contextualize their findings and build confidence in what they pursue.

Join one of our roadshows, or request one, to see how see how proteomics can help uncover meaningful biology, validate promising findings and translate insights towards clinical relevance.